Lexeo Therapeutics LXEO
NASDAQ LXEO
$3.38 -0.04 (-1.17%)
At close: Sep 30, 2026 · 4:00 PM EDT

Lexeo Therapeutics (LXEO) Revenue (2022)

Updated

Lexeo Therapeutics (LXEO) recorded Revenue of $654,000 in FY2022.

Analysis

Lexeo Therapeutics (LXEO) Revenue (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Lexeo Therapeutics 268.89 Mn 268.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 531,000.00
API Access

Lexeo Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=LXEO&period=max&api_key=YOUR_API_KEY